Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q2 2023 vs. Q1 2023
How the institutions holding Mesoblast Ltd changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 44 | 43 | −1 |
| Shares | 2.47M | 1.80M | −678.6K (−27.4%) |
| Value | $7.97M | $7.00M | −$970.4K (−12.2%) |
New holders (6)
Institutions that held Mesoblast Ltd at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Jane Street Group, LLC | 109,272 | $413.1K | 0.00% |
| Lazari Capital Management, Inc. | 86,034 | $336.4K | 0.19% |
| Evergreen Capital Management LLC | 16,012 | $62.6K | 0.00% |
| Rhumbline Advisers | 15,113 | $59.1K | 0.00% |
| Merit Financial Group, LLC | 13,406 | $52.4K | 0.00% |
| Creative Planning | 12,705 | $49.7K | 0.00% |
Sold out (7)
Institutions that held Mesoblast Ltd at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| M&G Investment Management Ltd | 580,946 | $1.74M |
| State Street Corp | 230,000 | $756.7K |
| Hennion & Walsh Asset Management, Inc. | 168,915 | $556.0K |
| Dynamic Technology Lab Private Ltd | 17,016 | $56.0K |
| Belpointe Asset Management LLC | 4,120 | $13.6K |
| US Bancorp | 1,254 | $4.13K |
| CWM, LLC | 2 | $0 |